XTLB
XTL Biopharmaceuticals
XTLB
XTLB
3 hedge funds and large institutions have $2.45M invested in XTL Biopharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
SM
1
Sabby Management
Miami Beach,
Florida
|
$2.21M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $2.21M | 1,150,981 | -160,472 | -12% |
|
2
Invesco
Atlanta,
Georgia
| $243K | 129,811 | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| – | – | -3,024 | Closed |
|
4
Morgan Stanley
New York
| $0 | 5 | +1 | +25% |
|